Pharmas cutting sales forces; Ranbaxy accused of distributing weak AIDS drugs;

> Pharmaceutical companies have been cutting sales forces recently. The most recent is Boehringer Ingelheim, which will halve the ranks of its neurology sales force. FiercePharma

> The ongoing investigation of generic drug maker Ranbaxy now includes a look at charges that it made weak or impure HIV drugs given to thousands of African AIDS patients. FiercePharma

> Researchers are working to develop a low-cost, next-gen pneumococcus vaccine that works against a wider range of pneumococcus bacteria than industry standard Prevnar. FierceVaccines

> According to a new study by healthcare IT company Logicalis, data storage is the top driver behind many hospital IT projects underway right now. FierceHealthIT

And Finally... Nice try, lady. Just drop the rat and put your hands up. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.